Ebbo, M., Grados, A., Samson, M., Groh, M., Loundou, A., Rigolet, A., . . . Schleinitz, N. (2017). Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients. PLoS One.
Dyfyniad Arddull ChicagoEbbo, Mikael, et al. "Long-term Efficacy and Safety of Rituximab in IgG4-related Disease: Data From a French Nationwide Study of Thirty-three Patients." PLoS One 2017.
Dyfyniad MLAEbbo, Mikael, et al. "Long-term Efficacy and Safety of Rituximab in IgG4-related Disease: Data From a French Nationwide Study of Thirty-three Patients." PLoS One 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.